Tate & Lyle plc (TATYY) Income Statement Analysis

See more : Elekta AB (publ) (0O5H.IL) Income Statement Analysis – Financial Results

Complete financial analysis of Tate & Lyle plc (TATYY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Tate & Lyle plc, a leading company in the Packaged Foods industry within the Consumer Defensive sector.

You may be interested

Stardust Power Inc. (SDSTW) Income Statement Analysis – Financial Results
SeAH Steel Corporation (306200.KS) Income Statement Analysis – Financial Results
Big Technologies plc (BIG.L) Income Statement Analysis – Financial Results
Suzhou Maxwell Technologies Co., Ltd. (300751.SZ) Income Statement Analysis – Financial Results
GPT Healthcare Limited (GPTHEALTH.NS) Income Statement Analysis – Financial Results

Tate & Lyle plc (TATYY)

Industry: Packaged Foods

Sector: Consumer Defensive

Website: https://www.tateandlyle.com

About Tate & Lyle plc

Tate & Lyle PLC, together with its subsidiaries, provides ingredients and solutions to the food, beverage, and other industries in the United States, the United Kingdom, other European countries, and internationally. It operates through three segments: Food & Beverage Solutions, Sucralose, and Primary Products. The company offers texturants; nutritive sweeteners, such as high fructose corn syrup and dextrose; health and wellness ingredients; and stabilizers. It also provides industrial starches for paper, packaging, and industrial adhesives; acidulants, such as citric acid; and commodities comprising corn gluten feed and meal for animal nutrition, as well as corn oil and ethanol. In addition, the company engages in the treasury and insurance businesses; and provision of research and development services. Tate & Lyle PLC was incorporated in 1903 and is headquartered in London, the United Kingdom.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999	1998	1997	1996	1995	1994	1993	1992	1991	1990	1989	1988	1987	1986
Revenue	1.65B	1.75B	1.38B	1.21B	2.88B	2.76B	2.71B	2.75B	2.36B	2.34B	3.15B	3.26B	3.09B	2.72B	2.53B	3.55B	2.87B	3.23B	3.47B	3.34B	2.58B	3.17B	3.94B	3.83B	0.00	4.12B	4.35B	4.88B	4.25B	4.07B	3.70B	3.29B	3.22B	3.39B	3.36B	2.09B	1.70B	1.65B	1.63B
Cost of Revenue	796.00M	1.26B	1.04B	908.00M	1.99B	1.52B	1.51B	1.60B	1.40B	1.44B	2.19B	2.28B	2.16B	1.81B	1.25B	2.03B	1.54B	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	235.30M	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Gross Profit	851.00M	496.00M	339.00M	303.00M	892.00M	1.24B	1.20B	1.15B	956.00M	906.00M	962.00M	975.00M	933.00M	912.00M	1.29B	1.53B	1.32B	3.23B	3.47B	3.34B	2.58B	3.17B	3.94B	3.83B	0.00	4.12B	4.12B	4.88B	4.25B	4.07B	3.70B	3.29B	3.22B	3.39B	3.36B	2.09B	1.70B	1.65B	1.63B
Gross Profit Ratio	51.67%	28.33%	24.65%	25.02%	30.95%	44.90%	44.17%	41.81%	40.59%	38.70%	30.57%	29.94%	30.21%	33.53%	50.81%	42.95%	46.18%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	0.00%	100.00%	94.59%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Research & Development	44.00M	46.00M	41.00M	42.00M	34.00M	36.00M	35.00M	37.00M	29.00M	32.00M	33.00M	32.00M	29.00M	25.00M	26.00M	28.00M	29.00M	15.00M	21.00M	20.00M	17.00M	18.00M	17.00M	13.00M	0.00	16.30M	22.40M	23.60M	29.00M	29.80M	22.20M	18.10M	15.20M	12.20M	15.90M	10.20M	5.70M	4.50M	0.00
General & Administrative	0.00	0.00	0.00	0.00	0.00	0.00	2.42B	-277.00M	-319.00M	-355.00M	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Selling & Marketing	0.00	0.00	0.00	0.00	0.00	0.00	-2.19B	496.00M	480.00M	478.00M	442.00M	427.00M	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
SG&A	265.00M	224.00M	132.00M	104.00M	541.00M	222.00M	226.00M	219.00M	161.00M	123.00M	442.00M	427.00M	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Expenses	335.00M	0.00	0.00	0.00	0.00	0.00	0.00	-7.00M	-6.00M	-8.00M	4.00M	71.00M	5.00M	-4.00M	-19.00M	-3.00M	4.00M	2.91B	-3.00M	-3.00M	-57.00M	26.00M	-13.00M	-298.00M	0.00	11.20M	3.90B	-3.00M	-2.30M	-900.00K	-700.00K	-3.90M	272.50M	270.40M	259.90M	127.30M	88.90M	71.90M	1.63B
Operating Expenses	644.00M	270.00M	173.00M	146.00M	575.00M	971.00M	885.00M	894.00M	808.00M	858.00M	630.00M	627.00M	2.74B	2.43B	2.34B	3.28B	2.61B	2.90B	3.15B	3.12B	2.37B	2.96B	3.78B	3.35B	0.00	3.91B	4.08B	4.58B	3.88B	3.77B	3.44B	3.06B	3.22B	3.39B	3.36B	2.09B	1.70B	1.65B	1.63B
Cost & Expenses	1.44B	1.53B	1.21B	1.05B	2.57B	2.49B	2.40B	2.50B	2.21B	2.29B	2.82B	2.91B	2.74B	2.43B	2.34B	3.28B	2.61B	2.90B	3.15B	3.12B	2.37B	2.96B	3.78B	3.35B	0.00	3.91B	4.08B	4.58B	3.88B	3.77B	3.44B	3.06B	3.22B	3.39B	3.36B	2.09B	1.70B	1.65B	1.63B
Interest Income	19.00M	12.00M	1.00M	1.00M	5.00M	26.00M	26.00M	24.00M	22.00M	23.00M	2.00M	1.00M	8.00M	3.00M	2.00M	10.00M	38.00M	50.00M	45.00M	34.00M	31.00M	34.00M	47.00M	32.00M	0.00	32.00M	27.70M	32.50M	24.40M	32.20M	38.80M	34.90M	29.60M	34.30M	41.50M	29.40M	13.30M	17.20M	0.00
Interest Expense	25.00M	29.00M	23.00M	22.00M	33.00M	31.00M	28.00M	28.00M	25.00M	32.00M	37.00M	97.00M	32.00M	50.00M	74.00M	59.00M	78.00M	83.00M	76.00M	56.00M	50.00M	60.00M	102.00M	99.00M	0.00	99.30M	88.60M	89.80M	78.30M	72.20M	85.90M	82.80M	79.30M	95.60M	111.70M	48.70M	19.00M	16.10M	0.00
Depreciation & Amortization	94.00M	95.00M	80.00M	97.00M	172.00M	152.00M	154.00M	149.00M	115.00M	109.00M	118.00M	108.00M	103.00M	109.00M	119.00M	132.00M	115.00M	93.00M	127.00M	132.00M	114.00M	118.00M	129.00M	132.00M	0.00	134.60M	144.70M	125.40M	135.20M	127.00M	103.80M	84.20M	78.00M	81.30M	91.10M	40.00M	22.50M	21.90M	0.00
EBITDA	345.00M	321.00M	168.00M	292.00M	501.00M	448.00M	436.00M	399.00M	286.00M	276.00M	353.00M	443.00M	455.00M	404.00M	77.00M	304.00M	375.00M	429.00M	217.00M	395.00M	380.00M	357.00M	382.00M	370.00M	0.00	399.30M	392.60M	491.50M	524.60M	473.00M	412.20M	356.50M	388.10M	394.90M	403.20M	208.80M	133.50M	119.50M	0.00
EBITDA Ratio	20.95%	18.33%	17.89%	20.97%	16.97%	16.26%	16.09%	14.49%	12.14%	11.79%	14.08%	13.64%	14.73%	14.82%	12.32%	10.84%	14.13%	14.33%	14.11%	11.47%	14.84%	11.21%	9.69%	9.67%	0.00%	9.76%	10.80%	9.92%	12.88%	11.56%	11.05%	10.89%	12.05%	11.64%	12.00%	10.00%	7.85%	7.27%	0.00%
Operating Income	207.00M	226.00M	166.00M	157.00M	317.00M	296.00M	282.00M	250.00M	171.00M	167.00M	325.00M	336.00M	404.00M	303.00M	-44.00M	164.00M	224.00M	302.00M	47.00M	229.00M	206.00M	224.00M	172.00M	151.00M	0.00	202.80M	202.80M	309.10M	348.10M	303.00M	259.30M	233.10M	233.10M	313.60M	312.10M	168.80M	111.00M	97.70M	0.00
Operating Income Ratio	12.57%	12.91%	12.07%	12.96%	11.00%	10.74%	10.41%	9.08%	7.26%	7.13%	10.33%	10.32%	13.08%	11.14%	-1.74%	4.62%	7.81%	9.36%	1.36%	6.86%	7.98%	7.07%	4.36%	3.95%	0.00%	4.93%	4.66%	6.34%	8.20%	7.44%	7.01%	7.08%	7.24%	9.24%	9.29%	8.08%	6.53%	5.94%	0.00%
Total Other Income/Expenses	19.00M	-44.00M	-25.00M	-26.00M	-54.00M	-56.00M	-4.00M	-29.00M	-51.00M	-150.00M	39.00M	-35.00M	-25.00M	-58.00M	-72.00M	-51.00M	-42.00M	-49.00M	-33.00M	-24.00M	18.00M	-37.00M	-13.00M	-341.00M	0.00	-37.40M	-112.60M	-32.80M	-37.00M	-29.20M	-36.80M	-43.60M	-2.30M	-95.60M	-111.70M	-48.70M	-19.00M	-16.20M	76.70M
Income Before Tax	226.00M	176.00M	42.00M	90.00M	268.00M	240.00M	286.00M	233.00M	126.00M	25.00M	290.00M	309.00M	379.00M	245.00M	-116.00M	113.00M	182.00M	253.00M	14.00M	205.00M	224.00M	152.00M	159.00M	-190.00M	0.00	165.40M	159.30M	276.30M	311.10M	273.80M	222.50M	189.50M	230.80M	218.00M	200.40M	120.10M	92.00M	81.50M	76.70M
Income Before Tax Ratio	13.72%	10.05%	3.05%	7.43%	9.30%	8.71%	10.55%	8.46%	5.35%	1.07%	9.22%	9.49%	12.27%	9.01%	-4.58%	3.18%	6.35%	7.84%	0.40%	6.14%	8.68%	4.80%	4.03%	-4.96%	0.00%	4.02%	3.66%	5.66%	7.32%	6.72%	6.02%	5.75%	7.17%	6.43%	5.96%	5.75%	5.41%	4.95%	4.71%
Income Tax Expense	47.00M	25.00M	16.00M	1.00M	51.00M	59.00M	23.00M	22.00M	5.00M	21.00M	45.00M	49.00M	72.00M	49.00M	-95.00M	19.00M	76.00M	88.00M	60.00M	55.00M	69.00M	57.00M	39.00M	40.00M	0.00	44.00M	50.30M	70.10M	84.50M	73.70M	55.00M	49.80M	64.80M	63.50M	65.20M	36.20M	28.10M	32.60M	76.70M
Net Income	188.00M	190.00M	236.00M	253.00M	245.00M	181.00M	265.00M	256.00M	121.00M	4.00M	273.00M	277.00M	305.00M	163.00M	15.00M	65.00M	194.00M	214.00M	-30.00M	146.00M	154.00M	97.00M	118.00M	-236.00M	0.00	124.00M	101.70M	174.00M	198.30M	171.10M	149.20M	116.10M	143.70M	176.90M	113.10M	70.20M	69.90M	26.80M	0.00
Net Income Ratio	11.41%	10.85%	17.16%	20.89%	8.50%	6.57%	9.78%	9.30%	5.14%	0.17%	8.67%	8.51%	9.88%	5.99%	0.59%	1.83%	6.77%	6.64%	-0.87%	4.37%	5.97%	3.06%	2.99%	-6.17%	0.00%	3.01%	2.34%	3.57%	4.67%	4.20%	4.03%	3.52%	4.46%	5.21%	3.37%	3.36%	4.11%	1.63%	0.00%
EPS	0.44	0.47	0.59	0.64	0.62	0.46	0.67	0.64	0.30	0.01	2.71	2.73	3.00	1.62	0.15	0.66	1.88	2.03	-0.29	1.43	1.52	0.95	1.15	-2.33	0.00	1.23	1.03	1.76	1.90	1.65	1.44	1.13	1.48	2.57	1.75	1.17	1.17	0.45	0.00
EPS Diluted	0.47	0.46	0.59	0.63	0.61	0.45	0.66	0.63	0.30	0.01	2.71	2.73	3.00	1.62	0.15	0.66	1.88	2.03	-0.29	1.43	1.52	0.95	1.15	-2.33	0.00	1.23	1.03	1.76	1.90	1.65	1.44	1.13	1.48	2.57	1.75	1.17	1.17	0.45	0.00
Weighted Avg Shares Out	423.42M	404.10M	398.66M	397.89M	397.89M	396.51M	396.26M	397.80M	397.97M	401.14M	100.82M	101.46M	101.64M	100.66M	97.93M	98.53M	102.94M	105.21M	102.15M	102.11M	101.23M	102.06M	102.79M	101.27M	118.15M	100.59M	98.99M	98.67M	104.40M	103.87M	103.37M	102.79M	97.11M	68.79M	64.54M	60.26M	59.66M	59.40M	69.30M
Weighted Avg Shares Out (Dil)	404.20M	411.40M	403.20M	402.34M	403.37M	402.43M	402.86M	403.89M	400.89M	401.14M	100.82M	101.46M	101.64M	100.66M	97.93M	98.53M	102.94M	105.21M	102.15M	102.11M	101.23M	102.06M	102.79M	101.27M	118.15M	100.59M	98.99M	98.67M	104.40M	103.87M	103.37M	102.79M	97.11M	68.79M	64.54M	60.26M	59.66M	59.40M	69.30M

Tate & Lyle trumpets leading position in ‘mouthfeel' solutions

November 7, 2024proactiveinvestors.co.uk

Tate & Lyle PLC (LSE:TATE) is in the final stages of its $1.8 billion acquisition of CP Kelco, a transaction the foodtech giant hopes will make it a global leader in the ‘mouthfeel' industry. Per a half-year trading update, regulatory...

Tate & Lyle: Mild profit-taking hits shares of takeover target

October 17, 2024proactiveinvestors.co.uk

After Wednesday's excitement, shares in Tate & Lyle PLC (LSE:TATE) succumbed to a mild bout of profit-taking in early trading. Late in yesterday's session, the Financial Times revealed Advent International is preparing a potential takeover bid for the food ingredient company.

PE firm Advent prepares takeover offer for UK's Tate & Lyle, FT reports

October 16, 2024reuters.com

Private equity firm Advent International is preparing a takeover offer for UK-based food and beverage ingredients maker Tate & Lyle , the Financial Times reported on Wednesday, citing two people familiar with the discussions.

Tate & Lyle remains a 'buy' - here's why

October 4, 2024proactiveinvestors.co.uk

Deutsche Bank has reiterated its "buy" rating for Tate & Lyle PLC (LSE:TATE), setting a price target of 850 pence, up from the last close of 669 pence. The bank highlights that the company's acquisition of CP Kelco is on...

Tate & Lyle axes shareholder vote on CP Kelco takeover

October 3, 2024proactiveinvestors.co.uk

Tate & Lyle PLC (LSE:TATE) has said shareholders will not receive a vote over its US$1.8 billion (£1.4 billion) takeover of CP Kelco. Under new UK listing rules which came into force in July, Tate & Lyle said approval from...

Tate & Lyle agrees to buy ingredients maker CP Kelco

June 20, 2024proactiveinvestors.co.uk

Tate & Lyle PLC (LSE:TATE), the food and beverage group, confirmed on Thursday it agreed to acquire ingredients company CP Kelco for US$1.8 billion (£1.4 billion) from JM Huber. The acquisition will include purchasing CP Kelco U.S., CP Kelco China,...

UK's sweetener maker Tate & Lyle to buy U.S.-based CP Kelco for $1.8 bln

June 20, 2024reuters.com

British food ingredients maker Tate & Lyle has entered into an agreement to buy U.S.-based CP Kelco for $1.8 billion from J.M. Huber Corporation, the company said on Thursday, as it seeks to strengthen its speciality food and beverage solutions...

Tate & Lyle plc (TATYF) Q4 2024 Earnings Call Transcript

May 23, 2024seekingalpha.com

Tate & Lyle plc (OTCQX:TATYF) Q4 2024 Results Conference Call May 23, 2024 5:00 AM ET Company Participants Nick Hampton - Chief Executive Officer Dawn Allen - Chief Financial Officer Conference Call Participants Damian Paul McNeela - Numis Securities Alex...

Tate & Lyle jumps on better profit and ingredients firm sale

May 23, 2024proactiveinvestors.co.uk

Tate & Lyle PLC (LSE:TATE) climbed over 4% on Thursday after announcing stronger profit over the last year and the sale of its remaining stake in Primient. Pre-tax profit climbed 18% to £287 million in the year to March, the...